April 2021 • PharmaTimes Magazine • 4-5
PharmaTimes talks to Professor James Litster, head of department of chemical and biological engineering at The University of Sheffield
Is blockchain the answer to protecting against counterfeits and medicines shortages?
What the government's planned reforms mean for healthcare
and pharma
A look at the recent dispute between the EU Commission and AstraZeneca over the ins and outs of its contract
Abbott’s Dr Nick West talks to PharmaTimes about going beyond intervention to improve the care of cardiovascular patients in the UK
OVID Health founder Jenny Ousbey discusses the pandemic, patient advocacy and the Patient Partnership Index
42-43.
Appointments